Tavexia Lifecare Board Approves Un-Audited Results, Fund Raise Proposal

Tavexia Lifecare Ltd announced the outcome of its Board Meeting held on November 4, 2026. The Board approved the Un-Audited Financial Results (Standalone and consolidated) for the Quarter and half-year ended September 30, 2026, along with the Limited Review Report. A proposal for raising funds up to ₹68 Crore for the proposed acquisition of 60% equity in Meyonex Pharmaceuticals Limited received in-principle approval. The Board also approved the change of Registrar & Transfer Agent from Niche Technologies Pvt. Ltd to Skyline Financial Services Pvt. Ltd.